8-K
filed January 31, 2023, 6:59 PM ET
ticker SYK
CIK 0000310764
earnings
confidence high
sentiment positive
materiality 0.80
Stryker Q4 organic sales +13.2%, adj. EPS $3.00; FY23 adj. EPS guide $9.85-10.15
STRYKER CORP
2022-FY EPS reported
$6.17
revenue$18,449,000,000
- Q4 reported sales $5.2B (+10.7% YoY); organic sales +13.2% driven by MedSurg and Neurotechnology (+16.9% organic).
- Q4 reported EPS $1.47 (-15.0%); adjusted EPS $3.00 (+10.7%) – includes $216M goodwill impairment in Spine.
- Full-year sales $18.4B (+7.8% reported); organic sales +9.7%; adjusted EPS $9.34 (+2.8%).
- 2023 outlook: organic sales growth 7.0-8.5%; adjusted EPS $9.85-$10.15.
- Adjusted operating margin contracted 70 bps in Q4 to 26.6% and 180 bps for FY to 23.8%.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
STRYKER CORP reported 2023 outlook results: EPS $9.85 to $10.15. Guidance initiated.
- Period
- 2023 outlook
- EPS
- $9.85 to $10.15
- Guidance
- initiated
- Result
- guidance update
Exact text from the filing
We expect 2023 organic net sales growth (2) to be in the range of 7.0% to 8.5% and expect adjusted net earnings per diluted share (2) to be in the range of $9.85 to $10.15.
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
STRYKER CORP reported Full year 2022 results: revenue $18.4 billion, net income $3.6 billion, EPS $9.34.
- Period
- Full year 2022
- Revenue
- $18.4 billion
- Net income
- $3.6 billion
- EPS
- $9.34
- Result
- reported results
Exact text from the filing
Full Year Results • Reported net sales increased 7.8% to $18.4 billion • Organic net sales increased 9.7% • Reported operating income margin of 15.4% • Adjusted operating income margin (1) contracted 180 bps to 23.8% • Reported EPS increased 18.4% to $6.17 • Adjusted EPS (1) increased 2.8% to $9.34
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
STRYKER CORP reported Full year 2022 results: revenue $18.4 billion, net income $3.6 billion, EPS $9.34.
- Period
- Full year 2022
- Revenue
- $18.4 billion
- Net income
- $3.6 billion
- EPS
- $9.34
- Result
- reported results
Exact text from the filing
% (3.7) % 19.3 % 2.4 % 16.9 % Orthopaedics and Spine 4.3 (4.0) 8.3 (0.1) 8.4 Total 10.7 % (3.8) % 14.5 % 1.3 % 13.2 % Full Year Results • Reported net sales increased 7.8% to $18.4 billion • Organic net sales increased 9.7% • Reported operating income margin of 15.4% • Adjusted operating income margin (1) contracted 180 bps to 23.8% • Reported EPS increased 18.4%
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
STRYKER CORP reported Fourth quarter 2022 results: revenue $5.2 billion, net income $1.1 billion, EPS $3.00.
- Period
- Fourth quarter 2022
- Revenue
- $5.2 billion
- Net income
- $1.1 billion
- EPS
- $3.00
- Result
- reported results
Exact text from the filing
Fourth Quarter Results • Reported net sales increased 10.7% to $5.2 billion • Organic net sales increased 13.2% • Reported operating income margin of 15.6% • Adjusted operating income margin (1) contracted 70 bps to 26.6% • Reported EPS decreased 15.0% to $1.47 • Adjusted EPS (1) increased 10.7% to $3.00
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
STRYKER CORP reported Fourth quarter 2022 results: revenue $5.2 billion, net income $1.1 billion, EPS $3.00.
- Period
- Fourth quarter 2022
- Revenue
- $5.2 billion
- Net income
- $1.1 billion
- EPS
- $3.00
- Result
- reported results
Exact text from the filing
- January 31, 2023 - Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2022: Fourth Quarter Results • Reported net sales increased 10.7% to $5.2 billion • Organic net sales increased 13.2% • Reported operating income margin of 15.6% • Adjusted operating income margin (1) contracted 70 bps to 26.6% • Reported EPS decreased 15.0%
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.